NDC 57894-522-01

Rybrevant Faspro 3520 mg/22mL

AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) · INJECTION

No Recall History

Rybrevant Faspro is a injection containing amivantamab and hyaluronidase-lpuj (human recombinant) at a strength of 3520 mg/22mL. Manufactured by Janssen Biotech, Inc..

Key Facts

Brand Name: Rybrevant Faspro
Generic Name: AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
NDC Code (Package): 57894-522-01
NDC Code (Product): 57894-522
Manufacturer: Janssen Biotech, Inc.
Strength: 3520 mg/22mL
Dosage Form: INJECTION
Route: SUBCUTANEOUS
Marketing Status
Application #: BLA761484
Drug Class: Endoglycosidase [EPC]
Marketing Start: 02/13/2026

Recall History

No Recall History

View Full Drug Page

Rybrevant Faspro — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.